01518.HK
New Century Healthcare Holding Co. Limited
HKSE · Healthcare · Medical - Care Facilities · CN
HKD 0.22
−8.75%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.3B | 600.1M | 846.5M | 933.1M | 636.5M |
| Cost of Revenue | 866.5M | 424.2M | 501.5M | 526.0M | 434.3M |
| Gross Profit | 413.4M | 175.9M | 345.0M | 407.1M | 202.1M |
| Operating Expenses | |||||
| R&D Expense | 6.0M | 3.3M | 4.1M | 5.9M | 7.7M |
| SG&A Expense | 366.6M | 184.7M | 192.7M | 198.2M | 194.1M |
| General & Admin Expense | 184.0M | 119.5M | 125.4M | 129.9M | 131.8M |
| Selling & Marketing Expense | 99.6M | 65.1M | 67.4M | 68.3M | 62.3M |
| Other Expenses | 73.7M | 58.8M | 6.2M | 31.2M | 279.0M |
| Total Operating Expenses | 446.4M | 246.9M | 203.0M | 235.3M | 480.8M |
| Cost and Expenses | 1.3B | 671.1M | 704.5M | 761.3M | 915.1M |
| Operating Income (EBIT) | (33.0M) | (71.0M) | 142.0M | 171.8M | (278.6M) |
| Non-Operating | |||||
| Interest Income | 6.2M | 2.7M | 4.9M | 1.3M | 2.1M |
| Interest Expense | 10.4M | 6.5M | 7.6M | 8.1M | 13.0M |
| Net Interest Income | (8.9M) | (3.8M) | (2.2M) | (6.7M) | (11.0M) |
| Other Non-Op Income/Expense | (67.8M) | (3.5M) | (426.0K) | (5.7M) | (11.2M) |
| Non-Operating Income (excl Interest) | (54.5M) | (53.8M) | (766.0K) | (2.4M) | (155.6M) |
| EBT (Pre-Tax Income) | (100.8M) | (74.5M) | 141.5M | 166.1M | (289.9M) |
| Income Tax Expense | 54.4M | 24.6M | 47.8M | 34.1M | 1.7M |
| Bottom Line | |||||
| Net Income | (178.2M) | (115.3M) | 47.4M | 84.2M | (297.7M) |
| Earnings from Cont. Ops | (155.2M) | (99.1M) | 93.8M | 132.1M | (291.6M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (178.2M) | (115.3M) | 47.4M | 84.2M | (297.7M) |
| Per Share | |||||
| Basic EPS | (HK$0.37) | (HK$0.24) | HK$0.10 | HK$0.17 | (HK$0.62) |
| Diluted EPS | (HK$0.37) | (HK$0.24) | HK$0.10 | HK$0.17 | (HK$0.62) |
| Revenue Per Share | HK$2.65 | HK$1.24 | HK$1.75 | HK$1.93 | HK$1.32 |
| Shares | |||||
| Basic Shares Outstanding | 483.2M | 483.2M | 483.2M | 483.2M | 483.2M |
| Diluted Shares Outstanding | 483.2M | 483.2M | 483.2M | 483.2M | 483.2M |
| Profitability Metrics | |||||
| EBITDA | 81.6M | 3.3M | 170.7M | 234.2M | (209.5M) |
| D&A | 60.1M | 20.5M | 27.9M | 60.0M | 70.2M |
| EBIT | 21.5M | (17.2M) | 142.7M | 174.2M | (279.8M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026